150 related articles for article (PubMed ID: 9761368)
21. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells.
Greiner DL; Goldschneider I; Komschlies KL; Medlock ES; Bollum FJ; Schultz L
J Exp Med; 1986 Oct; 164(4):1129-44. PubMed ID: 3531380
[TBL] [Abstract][Full Text] [Related]
22. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
Tapley P; Shevde NK; Schweitzer PA; Gallina M; Christianson SW; Lin IL; Stein RB; Shultz LD; Rosen J; Lamb P
Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
Lyons BL; Smith RS; Hurd RE; Hawes NL; Burzenski LM; Nusinowitz S; Hasham MG; Chang B; Shultz LD
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1201-9. PubMed ID: 16505059
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.
Piao X; Paulson R; van der Geer P; Pawson T; Bernstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14665-9. PubMed ID: 8962111
[TBL] [Abstract][Full Text] [Related]
25. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of the NF-kappaB and IkappaB proteins in B cells from viable motheaten mice.
Khaled AR; Butfiloski EJ; Villas B; Sobel ES; Schiffenbauer J
Autoimmunity; 1999; 30(2):115-28. PubMed ID: 10435725
[TBL] [Abstract][Full Text] [Related]
27. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.
Mizuno K; Katagiri T; Hasegawa K; Ogimoto M; Yakura H
J Exp Med; 1996 Aug; 184(2):457-63. PubMed ID: 8760799
[TBL] [Abstract][Full Text] [Related]
29. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.
Shultz LD; Schweitzer PA; Rajan TV; Yi T; Ihle JN; Matthews RJ; Thomas ML; Beier DR
Cell; 1993 Jul; 73(7):1445-54. PubMed ID: 8324828
[TBL] [Abstract][Full Text] [Related]
30. B and T cells are not required for the viable motheaten phenotype.
Yu CC; Tsui HW; Ngan BY; Shulman MJ; Wu GE; Tsui FW
J Exp Med; 1996 Feb; 183(2):371-80. PubMed ID: 8627150
[TBL] [Abstract][Full Text] [Related]
31. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro.
Medlock ES; Goldschneider I; Greiner DL; Shultz L
J Immunol; 1987 Jun; 138(11):3590-7. PubMed ID: 3584969
[TBL] [Abstract][Full Text] [Related]
32. The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages.
Roach TI; Slater SE; White LS; Zhang X; Majerus PW; Brown EJ; Thomas ML
Curr Biol; 1998 Sep; 8(18):1035-8. PubMed ID: 9740804
[TBL] [Abstract][Full Text] [Related]
33. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
34. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Kamata T; Yamashita M; Kimura M; Murata K; Inami M; Shimizu C; Sugaya K; Wang CR; Taniguchi M; Nakayama T
J Clin Invest; 2003 Jan; 111(1):109-19. PubMed ID: 12511594
[TBL] [Abstract][Full Text] [Related]
35. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.
Ono M; Okada H; Bolland S; Yanagi S; Kurosaki T; Ravetch JV
Cell; 1997 Jul; 90(2):293-301. PubMed ID: 9244303
[TBL] [Abstract][Full Text] [Related]
36. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
[TBL] [Abstract][Full Text] [Related]
37. Fetal liver pro-B and pre-B lymphocyte clones: expression of lymphoid-specific genes, surface markers, growth requirements, colonization of the bone marrow, and generation of B lymphocytes in vivo and in vitro.
Palacios R; Samaridis J
Mol Cell Biol; 1992 Feb; 12(2):518-30. PubMed ID: 1346335
[TBL] [Abstract][Full Text] [Related]
38. Identification of CD19(-)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow.
Ogawa M; ten Boekel E; Melchers F
Int Immunol; 2000 Mar; 12(3):313-24. PubMed ID: 10700466
[TBL] [Abstract][Full Text] [Related]
39. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia.
Beghini A; Ripamonti CB; Peterlongo P; Roversi G; Cairoli R; Morra E; Larizza L
Hum Mol Genet; 2000 Sep; 9(15):2297-304. PubMed ID: 11001933
[TBL] [Abstract][Full Text] [Related]
40. Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice.
Hayashi S; Witte PL; Shultz LD; Kincade PW
J Immunol; 1988 Apr; 140(7):2139-47. PubMed ID: 2450912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
